Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
27.6M
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
6.16M
-
Shares change
-
-11K
-
Total reported value, excl. options
-
$2.09M
-
Value change
-
-$3.3K
-
Number of buys
-
6
-
Number of sells
-
-2
-
Price
-
$0.34
Significant Holders of BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) as of Q3 2022
14 filings reported holding PHGE - BiomX Inc. - Common stock, par value $0.0001 per share as of Q3 2022.
BiomX Inc. - Common stock, par value $0.0001 per share (PHGE) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.16M shares
of 27.6M outstanding shares and own 22.3% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (2.81M shares), JOHNSON & JOHNSON (2.13M shares), MMCAP International Inc. SPC (684K shares), ROYCE & ASSOCIATES LP (159K shares), MILLENNIUM MANAGEMENT LLC (87.8K shares), Virtu Financial LLC (68.8K shares), JANE STREET GROUP, LLC (59.8K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (58.7K shares), CITADEL ADVISORS LLC (31.9K shares), and RENAISSANCE TECHNOLOGIES LLC (30.3K shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.